Literature DB >> 9506832

Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.

R Bobik1, Y Hong, G Breier, J F Martin, J D Erusalimsky.   

Abstract

Vascular endothelial growth factor (VEGF) production was analysed in megakaryocytic cell lines and CD34+ haematopoietic progenitors following treatment with thrombopoietin (TPO). In CMK cells TPO caused a time- and dose-dependent increase in the levels of VEGF released into the medium. A similar effect was observed in UT-7/mpl cells transfected with the TPO receptor c-Mpl, but not in parental UT-7 cells. In CD34+ haematopoietic progenitor cell cultures TPO stimulated VEGF mRNA expression and VEGF protein release. Production of VEGF in CD34+ cultures increased with TPO-induced megakaryocytic differentiation, but not with erythroid or myelomonocytic differentiation induced respectively by erythropoietin and granulocyte-macrophage colony-stimulating factor. These results demonstrate that TPO stimulates VEGF release in c-Mpl-expressing cells and suggest that this process is an integral feature of the megakaryocytic differentiation programme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506832     DOI: 10.1016/s0014-5793(98)00056-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Differences between newborn and adult mice in their response to immune thrombocytopenia.

Authors:  Zhongbo Hu; William B Slayton; Lisa M Rimsza; Matthew Bailey; Hannes Sallmon; Martha C Sola-Visner
Journal:  Neonatology       Date:  2010-02-04       Impact factor: 4.035

2.  Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.

Authors:  Guosu Wang; Richard Franklin; Ying Hong; Jorge D Erusalimsky
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin.

Authors:  M Yagi; K A Ritchie; E Sitnicka; C Storey; G J Roth; S Bartelmez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha.

Authors:  Keita Kirito; Norma Fox; Norio Komatsu; Kenneth Kaushansky
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

Review 5.  The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control.

Authors:  Alessandro Malara; Vittorio Abbonante; Christian A Di Buduo; Lorenzo Tozzi; Manuela Currao; Alessandra Balduini
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

Review 6.  Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche.

Authors:  Huichun Zhan; Kenneth Kaushansky
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

7.  Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion.

Authors:  Jeong-Won Shin; Dong-Wha Lee; Moon-Jung Kim; Kyung-Soon Song; Han-Soo Kim; Hyun-Ok Kim
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

8.  Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Natalie A Mackow; Erich R Mackow
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

9.  Autocrine role of angiopoietins during megakaryocytic differentiation.

Authors:  Ernestina Saulle; Raffaella Guerriero; Alessia Petronelli; Elena Coppotelli; Marco Gabbianelli; Ornella Morsilli; Isabella Spinello; Elvira Pelosi; Germana Castelli; Ugo Testa; Simona Coppola
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.

Authors:  R Salgado; I Benoy; R Weytjens; D Van Bockstaele; E Van Marck; Ph Huget; M Hoylaerts; P Vermeulen; L Y Dirix
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.